U.K. gears up for oral cancer awareness campaign
The British Dental Health Foundation has announced details of the U.K.’s largest oral cancer action campaign. Mouth Cancer Action Month takes place in November and
The British Dental Health Foundation has announced details of the U.K.’s largest oral cancer action campaign. Mouth Cancer Action Month takes place in November and
Aspirin use appears to reduce the risk of Barrett’s esophagus, the largest known risk factor for esophageal cancer, according to a new study in Clinical
Researchers from Mount Sinai School of Medicine presented the outcomes of robotic surgery in tobacco users with head and neck cancer at the American Head
Electrochemotherapy appears to be safe and comparable to surgery in achieving control in squamous cell carcinoma of the head and neck (SCCHN), according to data
Canadian researchers will conduct a study to compare robotic surgery to radiation therapy for the treatment of oropharyngeal (OP) cancer. Researchers at the Lawson Health
Although the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of
A chemistry professor at the University of Connecticut has created a method for accurately detecting multiple proteins in the bloodstream that indicate the presence of
A growing body of evidence shows that oral sex is linked to the rising rate of head and neck cancer in young people, particularly oropharyngeal
The Australian minister for health has announced that, starting next school year, the government will provide free human papillomavirus (HPV) vaccinations (Gardasil) for 12- and
Actor and producer Michael Douglas has donated his time to help create a television public service announcement (PSA) on behalf of the Oral Cancer Foundation
The medical and scientific communities have been debating the potential relationship between mouthwash and oral cancer for decades. Now a new meta-analysis has found no
A new study by researchers at MD Anderson Cancer Center Orlando finds that tolfenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), can reduce esophageal tumors (Investigational